Earth Science Tech Inc (OTC: ETST) is a Florida-based holding company that acquires and operates businesses across pharmaceutical compounding, telemedicine, real estate development, and consumer products. The company generates revenue through its licensed compounding pharmacies (RxCompound and Mister Meds), asynchronous telemedicine platforms (Peaks and DOConsult), real estate development and financing through Avenvi, and consumer product sales under the MagneChef brand. Revenue grew 177% to $33.1 million for the fiscal year ended March 31, 2025, up from $12.0 million for the fiscal year ended March 31, 2024. Gross profit reached $24.3 million in FY2025, though total operating expenses of $20.9 million, led by $14.1 million in salaries, consumed the majority of that margin. Total assets were $7.1 million as of March 31, 2025. CEO Giorgio R. Saumat holds approximately 41.57% of common shares as of the filing date. The company is incorporated in Florida and pursuing additional pharmacy and telehealth licensure to expand its geographic footprint nationwide.

Revenue model

Transactional revenue from compounded prescription sales through RxCompound and Mister Meds pharmacies, telemedicine consultation fees through Peaks and DOConsult, real estate development and financing fees through Avenvi, and direct-to-consumer product sales under the MagneChef brand. Total revenue was $33.1 million for the fiscal year ended March 31, 2025. No segment-level revenue breakdown was disclosed in the excerpts.

Products and services

Licensed sterile and non-sterile compounded pharmaceutical preparations (RxCompound, Mister Meds); asynchronous telemedicine consultation and prescription generation (Peaks, DOConsult); real estate development, turnkey financing, and property management (Avenvi); kitchen and grilling accessories featuring a patented magnetic release mechanism (MagneChef). The Earth Science Foundation (ESF), a 501(c)(3) affiliate, provides financial assistance for prescriptions filled at the company's pharmacies.

Customers and end markets

Direct-to-consumer patients seeking compounded medications and telemedicine consultations; property buyers and real estate investors served by Avenvi; consumers purchasing kitchen and grilling accessories. No customer concentration data was disclosed in the excerpts.

Value-chain role

Vertically integrated operator combining pharmacy compounding, telemedicine prescription generation, and real estate infrastructure. Avenvi provides physical infrastructure support to the pharmacies and manages the company's share repurchase program. The telemedicine subsidiaries drive prescription flow to the compounding pharmacies, creating an internal patient-to-pharmacy channel.

Geographic exposure

Incorporated in Florida. As of the filing date (June 27, 2025), the company is pursuing additional licensure to expand pharmacy and telehealth operations nationwide. No specific state or revenue geographic breakdown was disclosed in the excerpts.

Competitors

National telehealth platforms, Vertically integrated pharmacy services, Digital health startups, Local and national real estate developers, Institutional real estate investors, Private equity real estate firms, Established kitchen and grilling accessory brands

Source: SEC 10-K, filed 2025-06-27

Industry: Pharmaceutical Preparations Peers: Kaya Holdings Inc Clarus Therapeutics Holdings, Inc. CANNABIS STRATEGIC VENTURES Gelstat Corp Panacea Life Sciences Holdings Inc Johnson & Johnson